BRIEF published on 06/03/2024 at 21:04, 2 years 3 months ago Ikonisys Completes Capital Increase to Boost Commercial Expansion Private Placement Capital Increase Commercial Expansion Ikonisys Hospitex Integration
PRESS RELEASE published on 06/03/2024 at 20:59, 2 years 3 months ago Inside Information / Other news releases Ikonisys announces €150k capital increase through private placement to accelerate commercial development. New funds strengthen financial resources for expansion Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
BRIEF published on 05/30/2024 at 07:35, 2 years 3 months ago Ikonisys Launches New Website to Promote FISH Technology and Total Automation in Healthcare Automation Healthcare Ikonisys FISH Technology Mass Screening
PRESS RELEASE published on 05/30/2024 at 07:30, 2 years 3 months ago Inside Information / Other news releases Ikonisys launches new website focusing on FISH technology and total automation in healthcare, enhancing mass cancer screening with advanced solutions and seamless integration Healthcare Ikonisys FISH Technology Mass Screening Total Automation
BRIEF published on 05/15/2024 at 07:35, 2 years 4 months ago Ikonisys: New international patent for Hospitex Ikonisys BLOCKfast Hospitalex International International Patent Cancer Diagnosis
PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 4 months ago Inside Information / Other news releases Hospitex International obtains international patent for BLOCKfast cyto-inclusion kit, enhancing global cancer diagnosis solutions. Company offers innovative diagnostics solutions in cytology Hospitex International BLOCKfast Cyto-inclusion Kit Global Commercial Development Cancer Diagnosis Solutions Cytology Diagnostics
PRESS RELEASE published on 02/06/2024 at 10:11, 2 years 7 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Ikonisys SA receives Buy recommendation and increased price target to EUR 6.30 from EUR 4.50 per share after acquiring Hospitex, an Italian-based cytology company Acquisition Strategic Partnership Ikonisys SA Hospitex Cancer Diagnostics
PRESS RELEASE published on 11/01/2023 at 11:26, 2 years 10 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 07/31/2023 at 07:56, 3 years 1 month ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 05/08/2023 at 08:37, 3 years 4 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy
Published on 09/19/2026 at 00:55, 2 hours 51 minutes ago Gossan Resources Announces Changes to Board and Management
Published on 09/18/2026 at 23:50, 3 hours 56 minutes ago Mako Mining Announces Equity Incentive Grants
Published on 09/18/2026 at 22:00, 5 hours 46 minutes ago Silver Tiger Announces Results of Annual and Special Meeting
Published on 09/18/2026 at 20:35, 7 hours 11 minutes ago Only 11% of Marketers Expect Google Search to Be Their Customers' Main Starting Point in Two Years
Published on 09/18/2026 at 14:30, 13 hours 16 minutes ago AIAI Holdings to Obtain a Controlling Position in Messier 42 Marketing Agreement
Published on 09/18/2026 at 18:44, 9 hours 2 minutes ago EQS-Adhoc: Enapter AG announces preliminary, unaudited figures for the first half of 2026 and restructures its US sales operations – one-off expense of EUR 17 million
Published on 09/18/2026 at 18:13, 9 hours 33 minutes ago Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:09, 9 hours 36 minutes ago Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:07, 9 hours 39 minutes ago Multi Units Luxembourg: NOTICE TO SHAREHOLDERS
Published on 09/18/2026 at 18:34, 9 hours 12 minutes ago Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/17/2026 at 17:40, 1 day 10 hours ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
